Literature DB >> 18319307

p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.

R Menassa1, V Tardy, F Despert, C Bouvattier-Morel, J P Brossier, M Cartigny, Y Morel.   

Abstract

CONTEXT: Steroid 21-hydroxylase deficiency is the most common enzymatic defect causing congenital adrenal hyperplasia with good genotype/phenotype relationships for common mutations. To determine the severity of rare mutations is essential for genetic counseling and better understanding of the structure-function of the cytochrome P450c21.
OBJECTIVE: The p.H62L mutation was the most frequent of 60 new mutations detected in 2900 steroid 21-hydroxylase deficiency patients, either isolated or associated on the same allele with a mild mutation (p.P453S, p.P30L, or partial promoter). Because phenotypes seemed to differ between patients with isolated or associated p.H62L, a detailed phenotype description and functional studies were performed.
RESULTS: Regarding phenotype, patients with isolated p.H62L had a nonclassical form, whereas patients with the association p.H62L + mild mutation had a simple virilizing form. Functional studies showed that p.H62L reduced the conversion of the two substrates, progesterone and 17-hydroxyprogesterone, in the same way as the mild p.P453S; the association p.H62L + p.P453S decreased enzymatic activity more strongly while conserving residual activity at a level intermediate between p.P453S and p.I172N. This suggested that p.H62L was a mild mutation, whereas a synergistic effect occurred when it was associated. Analysis of p.H62L in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects, the H62 being located in a domain implied in membrane anchoring.
CONCLUSION: According to phenotype and functional studies, p.H62L is a mild mutation, responsible for a more severe phenotype when associated with another mild mutation. These data are important for patient management and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319307     DOI: 10.1210/jc.2007-2701

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.

Authors:  Mayara Jorgens Prado; Simone Martins de Castro; Cristiane Kopacek; Maricilda Palandi de Mello; Thaiane Rispoli; Tarciana Grandi; Cláudia Maria Dornelles da Silva; Maria Lucia Rosa Rossetti
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

2.  Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients.

Authors:  Carolina Minutolo; Alejandro D Nadra; Cecilia Fernández; Melisa Taboas; Noemí Buzzalino; Bárbara Casali; Susana Belli; Eduardo H Charreau; Liliana Alba; Liliana Dain
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

3.  Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.

Authors:  Fernanda B Coeli; Fernanda C Soardi; Renan D Bernardi; Marcela de Araújo; Luciana C Paulino; Ivy F Lau; Reginaldo J Petroli; Sofia H V de Lemos-Marini; Maria T M Baptista; Gil Guerra-Júnior; Maricilda P de-Mello
Journal:  BMC Med Genet       Date:  2010-06-29       Impact factor: 2.103

4.  Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia.

Authors:  Ingeborg Brønstad; Lars Breivik; Paal Methlie; Anette S B Wolff; Eirik Bratland; Ingrid Nermoen; Kristian Løvås; Eystein S Husebye
Journal:  Endocr Connect       Date:  2014-04-15       Impact factor: 3.335

5.  Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency.

Authors:  Violeta Anastasovska; Tatjana Milenković; Mirjana Kocova
Journal:  J Med Biochem       Date:  2014-10-08       Impact factor: 3.402

6.  H62L Mutation of CYP21A2 Identified in the Non-classical Form of 21-Hydroxylase Deficiency.

Authors:  Keisuke Nagasaki; Takeshi Usui; Tadashi Asami; Yohei Ogawa; Toru Kikuchi; Makoto Uchiyama
Journal:  Clin Pediatr Endocrinol       Date:  2009-11-11

7.  A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): prediction of its structural and functional implications by computational methods.

Authors:  Sudhisha Dubey; Susan Idicula-Thomas; Mohammad Anwaruddin; Chinnaraj Saravanan; R Raveendra Varma; Anurupa Maitra
Journal:  J Biomed Sci       Date:  2009-01-08       Impact factor: 8.410

8.  Isolated p.H62L Mutation in the CYP21A2 Gene in a Simple Virilizing 21-Hydroxylase Deficient Patient.

Authors:  Melisa Taboas; Cecilia Fernández; Susana Belli; Noemi Buzzalino; Liliana Alba; Liliana Dain
Journal:  Case Rep Genet       Date:  2013-07-07

9.  Functional studies of p.R132C, p.R149C, p.M283V, p.E431K, and a novel c.652-2A>G mutations of the CYP21A2 gene.

Authors:  Melisa Taboas; Luciana Gómez Acuña; María Florencia Scaia; Carlos D Bruque; Noemí Buzzalino; Mirta Stivel; Nora R Ceballos; Liliana Dain
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

10.  Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations.

Authors:  Carlos D Bruque; Marisol Delea; Cecilia S Fernández; Juan V Orza; Melisa Taboas; Noemí Buzzalino; Lucía D Espeche; Andrea Solari; Verónica Luccerini; Liliana Alba; Alejandro D Nadra; Liliana Dain
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.